Olysio

Pharma

Feds zero in on J&J's blockbuster marketing

Johnson & Johnson is facing a fresh round of marketing scrutiny, with federal and state investigators probing the promotion of top arthritis and hep C meds.

Arlene Weintraub May 9, 2017 10:43am

FDA slaps hep B comeback warning on hep C wonder drugs

Oct 5, 2016 10:31am

Gilead's hep C sales will 'erode massively' as market wanes: Analyst

Sep 27, 2016 12:08pm